Lipid Nanoparticles Potentiate CpG-Oligodeoxynucleotide-Based Vaccine for Influenza Virus
出版年份 2020 全文链接
标题
Lipid Nanoparticles Potentiate CpG-Oligodeoxynucleotide-Based Vaccine for Influenza Virus
作者
关键词
-
出版物
Frontiers in Immunology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-01-09
DOI
10.3389/fimmu.2019.03018
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Plasmacytoid Dendritic Cells: Development, Regulation, and Function
- (2019) Boris Reizis IMMUNITY
- Below the surface: The inner lives of TLR4 and TLR9
- (2019) Laura Marongiu et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Lipid nanoparticles of Type-A CpG D35 suppress tumor growth by changing tumor immune-microenvironment and activate CD8 T cells in mice
- (2019) Lisa Munakata et al. JOURNAL OF CONTROLLED RELEASE
- Overcoming Barriers in the Path to a Universal Influenza Virus Vaccine
- (2018) Lynda Coughlan et al. Cell Host & Microbe
- Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity
- (2018) Shinu John et al. VACCINE
- Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility
- (2018) Jayesh A. Kulkarni et al. Nucleic Acid Therapeutics
- Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides
- (2018) Hideki Takahashi et al. Frontiers in Immunology
- A unique nanoparticulate TLR9 agonist enables a HA split vaccine to confer FcγR-mediated protection against heterologous lethal influenza virus infection
- (2018) Takuya Yamamoto et al. INTERNATIONAL IMMUNOLOGY
- Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies
- (2017) Silvie Van den Hoecke et al. JOURNAL OF VIROLOGY
- Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques
- (2017) Frank Liang et al. MOLECULAR THERAPY
- Lipid Nanoparticle Systems for Enabling Gene Therapies
- (2017) Pieter R. Cullis et al. MOLECULAR THERAPY
- Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
- (2017) Kapil Bahl et al. MOLECULAR THERAPY
- Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
- (2017) Norbert Pardi et al. NATURE
- Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
- (2017) Norbert Pardi et al. Nature Communications
- Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design
- (2017) Sinthujan Jegaskanda et al. Human Vaccines & Immunotherapeutics
- Recent progress in gene therapy to deliver nucleic acids with multivalent cationic vectors
- (2016) Elena Junquera et al. ADVANCES IN COLLOID AND INTERFACE SCIENCE
- Influence of immunoglobulin isotype on therapeutic antibody function
- (2016) Stephen A. Beers et al. BLOOD
- 2014–2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type
- (2016) Richard K. Zimmerman et al. CLINICAL INFECTIOUS DISEASES
- Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?
- (2016) Karlynn E Neu et al. CURRENT OPINION IN IMMUNOLOGY
- Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system
- (2016) F DeRosa et al. GENE THERAPY
- Lipid nanoparticles for targeted siRNA delivery – going from bench to bedside
- (2016) Victor Kotelianski et al. International Journal of Nanomedicine
- Beyond antigens and adjuvants: formulating future vaccines
- (2016) Tyson J. Moyer et al. JOURNAL OF CLINICAL INVESTIGATION
- Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles
- (2015) Srinivas Ramishetti et al. ACS Nano
- Advances in the development of influenza virus vaccines
- (2015) Florian Krammer et al. NATURE REVIEWS DRUG DISCOVERY
- Expression and Characterization of Recombinant, Tetrameric and Enzymatically Active Influenza Neuraminidase for the Setup of an Enzyme-Linked Lectin-Based Assay
- (2015) Marua Prevato et al. PLoS One
- Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration
- (2014) Sam Chen et al. JOURNAL OF CONTROLLED RELEASE
- Shielding of Lipid Nanoparticles for siRNA Delivery: Impact on Physicochemical Properties, Cytokine Induction, and Efficacy
- (2014) Varun Kumar et al. Molecular Therapy-Nucleic Acids
- Recent progress concerning CpG DNA and its use as a vaccine adjuvant
- (2013) Hidekazu Shirota et al. Expert Review of Vaccines
- Effect of polyethyleneglycol (PEG) chain length on the bio–nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells
- (2013) Daniela Pozzi et al. Nanoscale
- Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis
- (2013) Teresa Coelho et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cooperativity Between CD8+ T Cells, Non-Neutralizing Antibodies, and Alveolar Macrophages Is Important for Heterosubtypic Influenza Virus Immunity
- (2013) Brian J. Laidlaw et al. PLoS Pathogens
- Safety profile of RNAi nanomedicines
- (2012) Scott A. Barros et al. ADVANCED DRUG DELIVERY REVIEWS
- Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8+T-cell responses in melanoma patients
- (2012) Simone M. Goldinger et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Universal vaccine against influenza virus: Linking TLR signaling to anti-viral protection
- (2012) Nicole Schmitz et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system
- (2012) Nobutaka Hanagata International Journal of Nanomedicine
- Bottom-Up Design and Synthesis of Limit Size Lipid Nanoparticle Systems with Aqueous and Triglyceride Cores Using Millisecond Microfluidic Mixing
- (2012) Igor V. Zhigaltsev et al. LANGMUIR
- Nonviral delivery of self-amplifying RNA vaccines
- (2012) A. J. Geall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adjuvant solution for pandemic influenza vaccine production
- (2012) C. H. Clegg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA
- (2012) Nathan M Belliveau et al. Molecular Therapy-Nucleic Acids
- Regulation of effector and memory T-cell functions by type I interferon
- (2011) Jonathan P. Huber et al. IMMUNOLOGY
- Antigen Delivery to Plasmacytoid Dendritic Cells via BST2 Induces Protective T Cell-Mediated Immunity
- (2011) J. Loschko et al. JOURNAL OF IMMUNOLOGY
- Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection
- (2010) K. El Bakkouri et al. JOURNAL OF IMMUNOLOGY
- Memory and Effector CD8 T-cell Responses After Nanoparticle Vaccination of Melanoma Patients
- (2010) Daniel E. Speiser et al. JOURNAL OF IMMUNOTHERAPY
- Bifurcation of Toll-Like Receptor 9 Signaling by Adaptor Protein 3
- (2010) M. Sasai et al. SCIENCE
- Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial
- (2009) G. Senti et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Comparative Efficacy of Neutralizing Antibodies Elicited by Recombinant Hemagglutinin Proteins from Avian H5N1 Influenza Virus
- (2008) C.-J. Wei et al. JOURNAL OF VIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started